Abortion pill manufacturer sues FDA to preserve drug access.
TL;DR Summary
GenBioPro, the maker of the generic version of mifepristone, the majority of abortion pills sold in the US, has sued the FDA to protect its drug if courts revoke its approval. The lawsuit is part of the ongoing legal battle over a case filed in federal court in Texas seeking to overturn the FDA's 23-year-old approval of mifepristone. The company seeks to block the FDA from complying if the courts ultimately order mifepristone off the market. The case could have implications for the broader drug industry.
- Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market The New York Times
- Generic abortion pill maker sues FDA over its response to orders halting drug's approval CNN
- In fight over mifepristone, generic abortion pill maker sues FDA NPR
- Abortion pill maker sues FDA to preserve access POLITICO
- Abortion pill manufacturer sues FDA to keep drug on the market Axios
Reading Insights
Total Reads
0
Unique Readers
25
Time Saved
4 min
vs 4 min read
Condensed
89%
790 → 86 words
Want the full story? Read the original article
Read on The New York Times